110 related articles for article (PubMed ID: 8579931)
1. Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats.
Pan Z; Jee WS; Ma YF; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):291S-296S. PubMed ID: 8579931
[TBL] [Abstract][Full Text] [Related]
2. Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats.
Chen HK; Jee WS; Ma YF; Pan Z; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):285S-289S. PubMed ID: 8579930
[TBL] [Abstract][Full Text] [Related]
3. Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats.
Liang HH; Ma YF; Jee WS; Pan Z; Setterberg RB; McOsker JE; Li XJ
Bone; 1995 Oct; 17(4 Suppl):335S-339S. PubMed ID: 8579936
[TBL] [Abstract][Full Text] [Related]
4. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
[TBL] [Abstract][Full Text] [Related]
5. Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats.
Ma Y; Chen YY; Jee WS; Ke HZ; Ijiri K
Bone; 1995 Oct; 17(4 Suppl):267S-272S. PubMed ID: 8579927
[TBL] [Abstract][Full Text] [Related]
6. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
Li QN; Jee WS; Ma YF; Ke HZ; Xie H; Huang LF; Liang NC
Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
Ma YF; Lin BY; Jee WS; Lin CH; Chen YY; Ke HZ; Li XJ
J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandin E2 and risedronate administration on cancellous bone in older female rats.
Lin BY; Jee WS; Ma YF; Ke HZ; Kimmel DB; Li XJ
Bone; 1994; 15(5):489-96. PubMed ID: 7980959
[TBL] [Abstract][Full Text] [Related]
9. Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats.
Jee WS; Lin BY; Ma YF; Ke HZ
J Bone Miner Res; 1995 Jun; 10(6):963-70. PubMed ID: 7572321
[TBL] [Abstract][Full Text] [Related]
10. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE
J Bone Miner Metab; 1999; 17(1):18-22. PubMed ID: 10084397
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
Ke HZ; Jee WS; Zeng QQ; Li M; Lin BY
Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
Ma YF; Li XJ; Jee WS; McOsker J; Liang XG; Setterberg R; Chow SY
Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
[TBL] [Abstract][Full Text] [Related]
13. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats.
Baumann BD; Wronski TJ
Bone; 1995 Feb; 16(2):247-53. PubMed ID: 7756054
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
Jee WS; Mori S; Li XJ; Chan S
Bone; 1990; 11(4):253-66. PubMed ID: 2242291
[TBL] [Abstract][Full Text] [Related]
15. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
[TBL] [Abstract][Full Text] [Related]
16. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
Tang LY; Jee WS; Ke HZ; Kimmel DB
J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of cortical bone in human parathyroid hormone(1-84)-treated ovariectomized rats.
SamnegÄrd E; Iwaniec UT; Cullen DM; Kimmel DB; Recker RR
Bone; 2001 Mar; 28(3):251-60. PubMed ID: 11248654
[TBL] [Abstract][Full Text] [Related]
19. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
[TBL] [Abstract][Full Text] [Related]
20. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]